Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study.
Alyaa M AjabnoorSalwa S ZghebiRosa ParisiDarren M AshcroftMartin K RutterTim DoranMatthew J CarrMamas Andreas MamasEvangelos KontopantelisPublished in: PLoS medicine (2022)
The incidence of NVAF increased between 2009 and 2015, before plateauing. Underprescribing of OACs in NVAF is associated with a range of comorbidities, ethnicity, and socioeconomic factors, demonstrating the need for initiatives to reduce inequalities in the care for AF patients.
Keyphrases
- atrial fibrillation
- end stage renal disease
- oral anticoagulants
- risk factors
- left atrial appendage
- catheter ablation
- left atrial
- direct oral anticoagulants
- ejection fraction
- quality improvement
- chronic kidney disease
- primary care
- healthcare
- newly diagnosed
- palliative care
- peritoneal dialysis
- venous thromboembolism
- percutaneous coronary intervention
- patient reported outcomes
- emergency department
- pain management
- chronic pain
- health insurance
- mitral valve
- affordable care act